The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury

Transplant International

Volumn 28, Issue 12, 2015, Pages 1436-1444

  Gu, Haifeng ^a   Xie, Minghua ^b   Xu, Liqian ^a   Zheng, Xiaojun ^a   Yang, Yunmei ^a   Lv, Xueying ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b An Kang Hospital of Hangzhou Police   (China)

Author keywords

cardiac ischemia reperfusion injury; IL 17; IL 18 binding protein; Th17 cells

Indexed keywords

CARDIOVASCULAR AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 23; MESSENGER RNA; RECOMBINANT INTERLEUKIN 17; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOCYTE NECROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; GENE EXPRESSION; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NECROSIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; TH17 CELL; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; DISEASE MODEL; IMMUNOLOGY; ISOGRAFT; LEUKOCYTE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; NUDE MOUSE; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; IN VITRO TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOGRAFTS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MYOCARDIAL REPERFUSION INJURY; TH17 CELLS;

EID: 84960468307     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12683     Document Type: Article

References (42)

1. Wood KJ, Goto R,. Mechanisms of rejection: current perspectives. Transplantation 2012; 93: 1.
2. Robertson SE, Young JD, Kitson S, et al,. Expression and alternative processing of IL-18 in human neutrophils. Eur J Immunol 2006; 36: 722.
3. Dao T, Mehal WZ, Crispe IN,. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998; 161: 2217.
4. Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, Nakanishi K,. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 1997; 94: 3948.
5. Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B,. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J Biol Chem 2009; 284: 7853.
6. Dudler J, Simeoni E, Fleury S, et al,. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection. Transpl Int 2007; 20: 460.
7. Shimizu C, Matsumoto K, Fujita T, Fuke Y, Soma M,. Imbalance of interleukin-18 and interleukin-18 binding protein in patients with IgA nephropathy implicating renal vasculopathy. Clin Lab 2015; 61: 23.
8. Xu D, Chan WL, Leung BP, et al,. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998; 188: 1485.
9. Sareneva T, Julkunen I, Matikainen S,. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 2000; 165: 1933.
10. Kim SH, Eisenstein M, Reznikov L, et al,. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000; 97: 1190.
11. Fantuzzi G, Banda NK, Guthridge C, et al,. Generation and characterization of mice transgenic for human IL-18-binding protein isoform a. J Leukoc Biol 2003; 74: 889.
12. Millward JM, Lobner M, Wheeler RD, Owens T,. Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein. J Immunol 2010; 185: 2458.
13. Heron I,. A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A 1971; 79: 366.
14. Wiedemann D, Schneeberger S, Friedl P, et al,. The fibrin-derived peptide Bbeta(15-42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model. Transplantation 2010; 89: 824.
15. Ozsoy M, Gonul Y, Bal A, et al,. Effect of IL-18 binding protein on hepatic ischemia-reperfusion injury induced by infrarenal aortic occlusion. Ann Surg Treat Res 2015; 88: 92.
16. Liao YH, Xia N, Zhou SF, et al,. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 2012; 59: 420.
17. Li J, Wu F, Zhang H, et al,. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009; 47: 512.
18. Brinks H, Boucher M, Gao E, et al,. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ Res 2010; 107: 1140.
19. Liu M, Chien CC, Burne-Taney M, et al,. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 2006; 17: 765.
20. Sims JE, Smith DE,. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89.
21. Zhang A, Mao X, Li L, et al,. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury. Transpl Int 2014; 27: 1077.
22. Zhu H, Cui D, Liu K, Wang L, Huang L, Li J,. Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model. Transpl Int 2014; 27: 87.
23. Vinten-Johansen J,. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61: 481.
24. Prasad A, Stone GW, Holmes DR, Gersh B,. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. Circulation 2009; 120: 2105.
25. Morgan MJ, Kim YS, Liu ZG,. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008; 18: 343.
26. Hamacher-Brady A, Brady NR, Gottlieb RA,. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 2006; 20: 445.
27. Nakamura M, Wang NP, Zhao ZQ, et al,. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000; 45: 661.
28. Cheng X, Taleb S, Wang J, et al,. Inhibition of IL-17A in atherosclerosis. Atherosclerosis 2011; 215: 471.
29. Xie JJ, Wang J, Tang TT, et al,. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185.
30. Erbel C, Chen L, Bea F, et al,. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009; 183: 8167.
31. Madhur MS, Lob HE, McCann LA, et al,. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55: 500.
32. Yuan J, Yu M, Lin QW, et al,. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. J Immunol 2010; 185: 4004.
33. Baldeviano GC, Barin JG, Talor MV, et al,. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 2010; 106: 1646.
34. Shichita T, Sugiyama Y, Ooboshi H, et al,. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009; 15: 946.
35. Li L, Huang L, Vergis AL, et al,. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120: 331.
36. Edgerton C, Crispin JC, Moratz CM, et al,. IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol 2009; 130: 313.
37. Okamura H, Tsutsi H, Komatsu T, et al,. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88.
38. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H,. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423.
39. Boraschi D, Dinarello CA,. IL-18 in autoimmunity: review. Eur Cytokine Netw 2006; 17: 224.
40. Veenbergen S, Smeets RL, Bennink MB, et al,. The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses. Ann Rheum Dis 2010; 69: 276.
41. Jiang HR, Wei X, Niedbala W, Lumsden L, Liew FY, Forrester JV,. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci 2001; 42: 177.
42. Santos LL, Milenkovski GP, Hall PH, et al,. IL-18 is redundant in T-cell responses and in joint inflammation in antigen-induced arthritis. Immunol Cell Biol 2006; 84: 166.